MedTrace Logo

Obstructive Sleep Apnea in Scleroderma and Pulmonary Involvement

NCT02740569 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 62

Last updated 2018-09-07

No results posted yet for this study

Summary

Scleroderma is an autoimmune disease with skin manifestations and may have pulmonary involvement. Obstructive sleep apnea (OSA) may also be seen in scleroderma. Less is known regarding the prevalence of OSA in scleroderma and its association with pulmonary involvement.

Conditions

  • Scleroderma, Systemic
  • Sleep Apnea, Obstructive
  • Pulmonary Disease

Interventions

OTHER

No intervention

Observational study. Intervention according to the clinical routines (not included in this part)

Sponsors & Collaborators

  • Marmara University

    lead OTHER

Principal Investigators

  • Yuksel Peker, MD, Prof · Marmara University Medical School

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-04-30
Primary Completion
2016-10-01
Completion
2016-10-01

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02740569 on ClinicalTrials.gov